Mutation provides new clues for treating immune ‘cold’ tumors
Immune checkpoint inhibitors (ICIs) emerged in the United States about 15 years ago as an exciting class of cancer treatments ...
Immune checkpoint inhibitors (ICIs) emerged in the United States about 15 years ago as an exciting class of cancer treatments ...
A joint research team led by Professor Eijiro Miyako of the Japan Advanced Institute of Science and Technology (Jaist), in ...
Complete researchers from the Cancer Center of the University of North Carolina have developed a "two in one" molecule "which ...
New research led by a team of scientists at the Indiana University School of Medicine and their collaborators has discovered ...
Researchers used a chemical compound to illuminate treatment-resistant cancers on imaging scans, in a breakthrough that could help healthcare professionals ...
Immunotherapies that mobilize the patient's immune system to fight cancer have become a mainstay of treatment. These therapies, including CAR ...
Using a genetic barcoding system and a new single-cell sequencing method, a research team from the Istituto Italiano di Tecnologia ...
For years, cancer researchers have noticed that more men than women have a deadly form of brain cancer called glioblastoma. ...
In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in the treatment of ...
Glioblastoma is a brain cancer with a very low chance of survival. Most drugs cannot cross the blood-brain barrier, which ...
© 2023 Manhattan Tribune -By Millennium Press
© 2023 Manhattan Tribune -By Millennium Press